semilicoisoflavone B
Identification
| Name | semilicoisoflavone B |
| CAS Number | 129280-33-7 |
| FDA UNII | T9TP371NFX |
| Molecular Formula | C20 H16 O6 |
| Molecular Weight | 352.34272000 |
| MDL Number | MFCD28100710 |
| Nikkaji Number | J885.813F |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 3.225 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for semilicoisoflavone B usage levels up to | not for fragrance use. |
| Recommendation for semilicoisoflavone B flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
5,7-
dihydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one
5,7,8'-
trihydroxy-2',2'-dimethyl-2'H-(3,6')bi(1-benzopyranyl)-4-one
PubMed:
Glycyrrhiza uralensis and Semilicoisoflavone B Reduce Aβ Secretion by Increasing PPARγ Expression and Inhibiting STAT3 Phosphorylation to Inhibit BACE1 Expression.
PubMed:
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
PubMed:
Metabolites identification of bioactive licorice compounds in rats.
PubMed:
Aldose reductase inhibitory compounds from Glycyrrhiza uralensis.